A password will be e-mailed to you.

Connection Between Dopamine and Behavior Related to Pain and Fear

Summary: Using optogenetics, researchers have identified a causal association between dopamine and avoidance behavior linked to pain and fear.

Source: University of Maryland School of Medicine.

Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance behavior related to pain and fear.

Researchers have long known that dopamine plays a key role in driving behavior related to pleasurable goals, such as food, sex and social interaction. In general, increasing dopamine boosts the drive toward these stimuli. But dopamine’s role in allowing organisms to avoid negative events has remained mysterious.

The new study establishes for the first time that dopamine is central in causing behavior related to the avoidance of specific threats. The work was published today in the journal Current Biology.

“This study really advances what we know about how dopamine affects aversively motivated behaviors,” said Joseph F. Cheer PhD, a professor in the UMSOM Department of Anatomy & Neurobiology and the study’s corresponding author. “In the past, we thought of dopamine as a neurotransmitter involved in actions associated with the pursuit of rewards. With this new information we can delve into how dopamine affects so many more kinds of motivated behavior.”

To better understand the role that dopamine plays in this process, Dr. Cheer and his colleagues, including principal author Jennifer Wenzel, PhD, a fellow in Dr. Cheer’s laboratory, studied rats, focusing on a particular brain area, the nucleus accumbens. This brain region plays a crucial role in linking the need or desire for a given reward – food, sex, etc. – with the motor response to actually obtain that reward.

To study the animals under natural conditions, they used optogenetics, a relatively new technique in which specific groups of neurons can be controlled by exposure to light. In this case, Dr. Cheer’s group used a blue laser to stimulate genetically modified rats whose dopamine neurons could be controlled to send out more or less dopamine. In this way, they were able to see how dopamine levels affected the animals’ behavior. The principal advantage of this approach: he could control dopamine levels even as the animals moved freely in their environment.

The researchers subjected the animals to small electric shocks, but also taught the animals how to escape the shocks by pressing a small lever. Using optogenetics, they controlled the amount of dopamine released by neurons in the nucleus accumbens. Animals with high levels of dopamine in this brain region learned to avoid a shock more quickly and more often than animals that had a lower level of dopamine in this region.

Dr. Cheer says that this indicates that dopamine causally drives animals to avoid unpleasant or painful situations and stimuli. The results greatly expand the role that dopamine plays in driving behavior.

The researchers also examined the role that endocannabinoids play in this process. Endocannabinoids, brain chemicals that resemble the active ingredients in marijuana, play key roles in many brain processes. Here, Dr. Cheer and his colleagues found that endocannabinoids essentially open the gate that allows the dopamine neurons to fire. When the researchers reduced the level of endocannabinoids, the animals were much less likely to move to avoid shocks.

dopamine

Dr. Cheer says that this indicates that dopamine causally drives animals to avoid unpleasant or painful situations and stimuli. The results greatly expand the role that dopamine plays in driving behavior. NeuroscienceNews.com image is in the public domain.

Dr. Cheer argues that the research sheds light on brain disorders such as post-traumatic stress disorder and depression. In depression, patients feel unable to avoid a sense of helplessness in the face of problems, and tend to ruminate rather than act to improve their situation. In PTSD, patients are unable to avoid an overwhelming sense of fear and anxiety in the face of seemingly low-stress situations. Both disorders, he says, may involve abnormally low levels of dopamine, and may be seen on some level as a failure of the avoidance system.

In both depression and PTSD, doctors already sometimes treat patients with medicine to increase dopamine and there are now clinical trials testing use of endocannabinoid drugs to treat these conditions. Dr. Cheer suggests that this approach may need to be used more often, and should certainly be studied in more detail.

About this neuroscience research article

Source: David Kohn – University of Maryland School of Medicine
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: Open access research for “Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain” by Jennifer M. Wenzel, Erik B. Oleson, Willard N. Gove, Anthony B. Cole, Utsav Gyawali, Hannah M. Dantrassy, Rebecca J. Bluett, Dilyan I. Dryanovski, Garret D. Stuber, Karl Deisseroth, Brian N. Mathur, Sachin Patel, Carl R. Lupica, and Joseph F. Cheer in Current Biology. Published April 19 2018.
doi:10.1016/j.cub.2018.03.037

Cite This NeuroscienceNews.com Article
University of Maryland School of Medicine ” Connection Between Dopamine and Behavior Related to Pain and Fear.” NeuroscienceNews. NeuroscienceNews, 19 April 2018.
<http://neurosciencenews.com/dopamine-fear-pain-behavior-8842/>.
University of Maryland School of Medicine (2018, April 19). Connection Between Dopamine and Behavior Related to Pain and Fear. NeuroscienceNews. Retrieved April 19, 2018 from http://neurosciencenews.com/dopamine-fear-pain-behavior-8842/
University of Maryland School of Medicine ” Connection Between Dopamine and Behavior Related to Pain and Fear.” http://neurosciencenews.com/dopamine-fear-pain-behavior-8842/ (accessed April 19, 2018).

Abstract

Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain

Highlights
•Optogenetic stimulation of midbrain dopamine cells enhances active avoidance
•Accumbal D1 antagonism diminishes avoidance
•Midbrain endocannabinoid antagonism attenuates avoidance and dopamine release
•Well-learned avoidance is no longer controlled by this endocannabinoid/dopamine signal

Summary
Phasic dopamine (DA) release accompanies approach toward appetitive cues. However, a role for DA in the active avoidance of negative events remains undetermined. Warning signals informing footshock avoidance are associated with accumbal DA release, whereas depression of DA is observed with unavoidable footshock. Here, we reveal a causal role of phasic DA in active avoidance learning; specifically, optogenetic activation of DA neurons facilitates avoidance, whereas optical inhibition of these cells attenuates it. Furthermore, stimulation of DA neurons during presentation of a fear-conditioned cue accelerates the extinction of a passive defensive behavior (i.e., freezing). Dopaminergic control of avoidance requires endocannabinoids (eCBs), as perturbing eCB signaling in the midbrain disrupts avoidance, which is rescued by optical stimulation of DA neurons. Interestingly, once the avoidance task is learned, neither DA nor eCB manipulations affect performance, suggesting that once acquisition occurs, expression of this behavior is subserved by other anatomical frameworks. Our findings establish an instrumental role for DA release in learning active responses to aversive stimuli and its control by eCB signaling.

Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.
No more articles